NCT04024462 2026-02-20A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast CancerHoffmann-La RochePhase 3 Completed200 enrolled 16 charts
NCT02448173 2026-02-02A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon CancerVaccinogen IncPhase 3 Not yet recruiting550 enrolled